Showing results (131-140 of 142) with videos related to
Sort By:
Pageof 15
Journal of Cardiovascular Pharmacology|October 1, 1988
Clinical pharmacology of hydroxy-3(S)-dihydroquinidine in healthy volunteers following oral administrationB Lecocq, P Jaillon, V Lecocq, et al.Annales De Biologie Clinique|June 14, 2003
[A new, rapid and robust genotyping method for CYP2C9 and MDR1]C Verstuyft, S Morin, J Yang, et al.Clinical Pharmacology and Therapeutics|August 1, 1989
Pharmacokinetics of nalbuphine in infants, young healthy volunteers, and elderly patientsP Jaillon, M E Gardin, B Lecocq, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2000
Long-term outcome and treatment modifications in a prospective cohort of human immunodeficiency virus type 1-infected patients on triple-drug antiretroviral regimens. Triest Cohort InvestigatorsP M Girard, M Guiguet, D Bollens, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1989
[Electrophysiologic effects of intravenous 3-hydroxy-dihydroquinidine (LNC-834) in man]J Weissenburger, J Y le Heuzey, J Clementy, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|October 1, 1985
[Anti-arrhythmia effect of long-term encainide in chronic ventricular extrasystole]P Dumoulin, P Jaillon, A Kher, et al.American Heart Journal|September 1, 1985
Long-term efficacy and safety of oral encainide in the treatment of chronic ventricular ectopic activity: relationship to plasma concentrations--a French multicenter trialP Dumoulin, P Jaillon, A Kher, et al.The American Journal of Cardiology|March 1, 1985
Suppression of arrhythmias within hours after a single oral dose of amiodarone and relation to plasma and myocardial concentrationsB Escoubet, P Coumel, J M Poirier, et al.Clinical Pharmacology and Therapeutics|May 1, 1996
Assessment of individual CYP2D6 activity in extensive metabolizers with renal failure: comparison of sparteine and dextromethorphanJ P Kévorkian, C Michel, U Hofmann, et al.The American Journal of Cardiology|March 15, 1996
Effects of bisoprolol on heart rate variability in heart failureF Pousset, X Copie, P Lechat, et al.Pageof 15